Lipocine Inc. director John W. Higuchi picks up 150,000 shares worth $225,225
After the purchase, the filing lists 391,365 shares held.
John W. Higuchi purchased $225,225 of Lipocine Inc. (LPCN) stock between Nov 19 and Nov 20, according to an SEC filing. The director paid an average of $1.50 for 150,000 shares.
It is an open-market purchase (transaction code P) of common stock, the kind of trade insiders make with their own money. It is the fourth insider purchase at Lipocine Inc. reported in the last 90 days.
The trade was reported within two business days, as Section 16 requires. With this purchase the insider holds 391,365 shares, 62% more than before.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Lipocine Inc. (LPCN) |
|---|---|
| Insider | John W. Higuchi |
| Role | Director |
| Transaction | Open-market purchase (code P) |
| Shares | 150,000 |
| Average price | $1.50 |
| Value | $225,225 |
| Trade dates | Nov 19 to Nov 20, 2026 |
| Filed with the SEC | Nov 20, 2026, 5:28 PM ET |
| Shares held after | 391,365 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See the detailed report on this LPCN purchase
See the latest cluster buys and sells · Browse the insider trading newsroom
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.